Drug intelligence / Profile preview

XiaoYanTuiRe Granules

Development stage: Unknown
Lead developer: Shanxi Buchang Pharmaceutical
Administration: Oral

Overview

XiaoYanTuiRe Granules is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanxi Buchang Pharmaceutical. It is formulated as oral granules and is primarily indicated for the treatment of inflammation and fever, particularly those associated with respiratory tract infections. As a botanical-based therapy, it typically comprises a combination of herbal extracts, such as *Andrographis paniculata*, *Taraxacum mongolicum*, and *Isatis tinctoria*, which are traditionally used for their antipyretic and anti-inflammatory properties. The product is approved for marketing in China and is positioned within the company's respiratory product portfolio.

Brand names: XiaoYanTuiRe Granules
Other names: Xiaoyan Tuire Keli消炎退热颗粒

Beyond the preview

Go deeper on XiaoYanTuiRe Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XiaoYanTuiRe Granules.

Explore the full profile